Response to eLetter: 'Discussion of methotrexate dosage' by Maguire
et al
Ann Rheum Dis
.
2018 Aug;77(8):e48.
doi: 10.1136/annrheumdis-2017-212380.
Epub 2017 Oct 9.
Authors
Mary Safy
1
,
J W G Jacobs
1
,
Nicole D Ijff
1
,
J W J Bijlsma
1
,
J M van Laar
1
,
Maria J H de Hair
1
;
Society for Rheumatology Research Utrecht (SRU)
Affiliation
1
Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
PMID:
28993345
DOI:
10.1136/annrheumdis-2017-212380
No abstract available
Keywords:
disease activity; methotrexate; treatment.
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid*
Follow-Up Studies
Humans
Methotrexate*
Prednisone
Substances
Prednisone
Methotrexate